Literature DB >> 26947599

Visceral Adiposity is Preferentially Associated with Vascular Stiffness Rather than Thickness in Men with Type 2 Diabetes.

Hirokazu Morigami1, Tomoaki Morioka, Yuko Yamazaki, Satoshi Imamura, Ryutaro Numaguchi, Mariko Asada, Koka Motoyama, Katsuhito Mori, Shinya Fukumoto, Tetsuo Shoji, Masanori Emoto, Masaaki Inaba.   

Abstract

AIM: Visceral fat accumulation is known to underlie the clustering of cardiovascular risk factors. However, it is not completely understood how visceral fat accumulation influences the development of cardiovascular disease. In this study, we investigated the clinical impact of visceral adiposity on vascular stiffness and thickness in patients with type 2 diabetes (T2D).
METHODS: One hundred and sixty-one patients with T2D, including 92 men and 69 women, were included in this cross-sectional study. Visceral fat area (VFA) and subcutaneous fat area (SFA) were measured by dual bioelectrical impedance analysis. Stiffness parameter β and intima-media thickness (IMT) of the common carotid artery were measured by ultrasonography.
RESULTS: The mean age and duration of diabetes in the study population were 61 years and 13.9 years, respectively. In men, VFA and waist circumference (WC) were positively correlated with stiffness parameter β, whereas body mass index (BMI), WC, and SFA were negatively correlated with IMT. In contrast, in women, none of the obesity-related indices were significantly correlated with stiffness parameter β or IMT. In multiple regression analyses, VFA as well as WC, BMI, and SFA were independently associated with stiffness parameter β after adjustment for age and other potential confounders in men but not in women. None of the obesity-related indices were independently associated with IMT for either sex.
CONCLUSION: In men with T2D, visceral adiposity is associated with carotid arterial stiffness but not thickness.

Entities:  

Mesh:

Year:  2016        PMID: 26947599      PMCID: PMC5090813          DOI: 10.5551/jat.33399

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  46 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

Review 2.  Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures.

Authors:  Luc M Van Bortel; Daniel Duprez; Mirian J Starmans-Kool; Michel E Safar; Christina Giannattasio; John Cockcroft; Daniel R Kaiser; Christian Thuillez
Journal:  Am J Hypertens       Date:  2002-05       Impact factor: 2.689

3.  The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes.

Authors:  Michaela Diamant; Hildo J Lamb; Marcel A van de Ree; Edwin L Endert; Ymte Groeneveld; Michiel L Bots; Piet J Kostense; Jasper K Radder
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

5.  The utility of dual bioelectrical impedance analysis in detecting intra-abdominal fat area in obese patients during weight reduction therapy in comparison with waist circumference and abdominal CT.

Authors:  Hajime Yamakage; Ryo Ito; Mayu Tochiya; Kazuya Muranaka; Masashi Tanaka; Yoshiyuki Matsuo; Shinji Odori; Shigeo Kono; Akira Shimatsu; Noriko Satoh-Asahara
Journal:  Endocr J       Date:  2014-06-13       Impact factor: 2.349

6.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

7.  Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.

Authors:  Jacqueline M Dekker; Cynthia Girman; Thomas Rhodes; Giel Nijpels; Coen D A Stehouwer; Lex M Bouter; Robert J Heine
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

8.  Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.

Authors:  M Emoto; Y Nishizawa; T Kawagishi; K Maekawa; Y Hiura; H Kanda; K Izumotani; T Shoji; E Ishimura; M Inaba; Y Okuno; H Morii
Journal:  Diabetes Care       Date:  1998-07       Impact factor: 19.112

9.  Impact of increased visceral adiposity with normal weight on the progression of arterial stiffness in Japanese patients with type 2 diabetes.

Authors:  Ryotaro Bouchi; Isao Minami; Norihiko Ohara; Yujiro Nakano; Rie Nishitani; Masanori Murakami; Takato Takeuchi; Momoko Akihisa; Tatsuya Fukuda; Masamichi Fujita; Takanobu Yoshimoto; Yoshihiro Ogawa
Journal:  BMJ Open Diabetes Res Care       Date:  2015-03-10

10.  Leptin is associated with vascular endothelial function in overweight patients with type 2 diabetes.

Authors:  Tomoaki Morioka; Masanori Emoto; Yuko Yamazaki; Naoya Kawano; Satoshi Imamura; Ryutaro Numaguchi; Hiromi Urata; Koka Motoyama; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba
Journal:  Cardiovasc Diabetol       Date:  2014-01-10       Impact factor: 9.951

View more
  9 in total

1.  The Association Between Salivary Ghrelin Levels with Anthropometric Measures in Underweight, Normal, Overweight and Obese Healthy Adult Males.

Authors:  Mona Mohamed Ibrahim Abdalla; Soon Siew Choo
Journal:  Eur Endocrinol       Date:  2020-02-28

2.  Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes.

Authors:  Saori Maruo; Koka Motoyama; Tomoe Hirota; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2020-03-21

Review 3.  Is Stiffness Parameter β Useful for the Evaluation of Atherosclerosis?~ Its Clinical Implications, Limitations, and Future Perspectives ~.

Authors:  Tomoaki Morioka; Katsuhito Mori; Masanori Emoto
Journal:  J Atheroscler Thromb       Date:  2021-02-13       Impact factor: 4.928

4.  Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients with Type 2 Diabetes without Renal Dysfunction.

Authors:  Mariko Asada; Tomoaki Morioka; Yuko Yamazaki; Yoshinori Kakutani; Reina Kawarabayashi; Koka Motoyama; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masanori Emoto; Masaaki Inaba
Journal:  J Diabetes Res       Date:  2016-12-14       Impact factor: 4.011

Review 5.  Central Hemodynamics for Management of Arteriosclerotic Diseases.

Authors:  Junichiro Hashimoto
Journal:  J Atheroscler Thromb       Date:  2017-06-10       Impact factor: 4.928

6.  Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.

Authors:  Takeshi Sakura; Tomoaki Morioka; Atsushi Shioi; Yoshinori Kakutani; Yuya Miki; Yuko Yamazaki; Koka Motoyama; Katsuhito Mori; Shinya Fukumoto; Tetsuo Shoji; Masanori Emoto; Masaaki Inaba
Journal:  Cardiovasc Diabetol       Date:  2017-05-10       Impact factor: 9.951

7.  PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity.

Authors:  Ju-Yi Chen; Yi-Pin Wu; Chih-Yi Li; Huei-Fen Jheng; Ling-Zhen Kao; Ching-Chun Yang; Sy-Ying Leu; I-Chia Lien; Wen-Tsan Weng; Haw-Chih Tai; Yu-Wei Chiou; Ming-Jer Tang; Pei-Jane Tsai; Yau-Sheng Tsai
Journal:  J Biomed Sci       Date:  2021-03-29       Impact factor: 8.410

Review 8.  CIDE Family-Mediated Unique Lipid Droplet Morphology in White Adipose Tissue and Brown Adipose Tissue Determines the Adipocyte Energy Metabolism.

Authors:  Yuki Nishimoto; Yoshikazu Tamori
Journal:  J Atheroscler Thromb       Date:  2017-09-05       Impact factor: 4.928

9.  Adiposity measures and arterial stiffness in primary care: the MARK prospective observational study.

Authors:  Leticia Gomez-Sanchez; Luis Garcia-Ortiz; Maria C Patino-Alonso; Jose I Recio-Rodriguez; Fernando Rigo; Ruth Martí; Cristina Agudo-Conde; Emiliano Rodriguez-Sanchez; Jose A Maderuelo-Fernandez; Rafel Ramos; Manuel A Gomez-Marcos
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.